Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:900904)

Market Cap	3.30B +0.5%
Revenue (ttm)	1.88B -14.1%
Net Income	62.34M +23.7%
EPS	0.11 +12.1%
Shares Out	n/a
PE Ratio	52.92
Forward PE	n/a
Dividend	0.15 (29.34%)
Ex-Dividend Date	Jun 5, 2025

Volume	132,760
Average Volume	96,159
Open	0.5120
Previous Close	0.5120
Day's Range	0.5080 - 0.5160
52-Week Range	0.4600 - 0.5880
Beta	0.39
RSI	55.71
Earnings Date	Apr 30, 2026

About SHA:900904

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1990
• Employees: 1,266
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 900904

Financial Performance

In 2024, SHA:900904's revenue was 2.05 billion, a decrease of -12.48% compared to the previous year's 2.34 billion. Earnings were 71.39 million, an increase of 25.24%.